Figure 6i showed that AJAP1 could interact with β-catenin and the loss of AJAP1 could promote breast cancer progression and metastasis by stimulating β-catenin nuclear translocation and TCF/LEF1 transcriptional activity, increasing C-myc and CyclinD1 expression. The gene discussed is AJAP1; the disease is breast cancer.